Last month, the United States Department of Justice (“DOJ”) issued its “Civil Division Enforcement Priorities” memorandum, memorializing a shift from its predecessor administration’s policy on gender‑affirming healthcare...more
7/17/2025
/ Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Federal Funding ,
Gender Identity ,
Healthcare ,
Medicaid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Requirements ,
Whistleblowers
On January 8, 2025, Massachusetts Governor Maura Healey signed into law House Bill 5159 (the “Bill”). The Bill grants the state new regulatory powers to oversee and review health care transactions involving private equity...more
2/3/2025
/ Acquisitions ,
Commercial Bankruptcy ,
Compliance ,
False Claims Act (FCA) ,
Healthcare ,
Investors ,
Liability ,
Material Change Doctrine ,
Mergers ,
Penalties ,
Private Equity ,
Proposed Legislation ,
Real Estate Investments ,
Regulatory Agenda ,
REIT
On June 27, 2023, the Office of Inspector General (“OIG”) for the U.S. Department of Health and Human Services (“HHS”) released its final rule (“Final Rule”) implementing penalties for information blocking....more
7/26/2023
/ 21st Century Cures Act ,
Compliance ,
Department of Health and Human Services (HHS) ,
Digital Health ,
Electronic Health Record Incentives ,
False Claims Act (FCA) ,
Federal Trade Commission (FTC) ,
Final Rules ,
Health Care Providers ,
Health Information Technologies ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Information Blocking Rules ,
OIG ,
Penalties ,
Regulatory Requirements ,
Technology